2017 - 2018 Academic Year
DEB/ECH 294 Schedule

2018 Spring Schedule

All seminars are scheduled from 11:00am to 12:00pm unless otherwise stated

April 6, 2018
LSA 1022

Organizational Meeting
Dr. Judy Kjelstrom - Co-Instructor, Biotechnology Program & DEB Program Coordinator
Prof. Karen McDonald - Co-Instructor, ECH
Co-Prof. Ray Rodriguez - Co-Instructor, MCB

April 13, 2018
LSA 1022

From lipid bilayers to bispecific antibodies, how a Chemical Engineer falls into (and in love with) Clinical Development
Michael Howland, PhD (DEB Alum)
Clinical Scientist

Genentech, Inc., South San Francisco, CA

April 20, 2018
Student Community Center

ESTEME Colloquium

Regulatory Affairs: Liaising with Health Authorities to Develop Cutting-Edge Therapies that are Safe and Effective
Anna Marie Tuazon, PhD (DEB Alum)
Associate Manager,
Regulatory Affairs
Gilead Sciences Inc.,
San Francisco Bay Area, CA

Co-sponsored by BMDCB Grad Group

April 27, 2018
LSA 1022

Pivoting in Pharma with a PhD
Allison Hoch, PhD (DEB Alum)
Medical Science Liaison
Boehringer Ingelheim, San Francisco Bay Area, CA

May 4, 2018
LSA 1022

Synthego: from Space-X to Genome Engineering Solutions
Kevin Holden, Ph.D (DEB Alum)
Head of Synthetic Biology
Synthego Corporation, Redwood City, CA


May 11, 2018
LSA 1022

10 years after graduating - how will the DEB influence your future?
Mike Plesha, PhD (DEB Alum)
Manufacturing Science & Technology Lead, Biologics R&D

Bayer CropScience, West Sacramento, CA

and
Identifying new technologies for Bayer Biologics
Damian Curtis, PhD
Microbial Genetic Systems Lead

Bayer Biologics, West Sacramento, CA

 

May 18, 2018

LSA 1022

 

 

 

Large scale analysis of food ingredient metatranscriptomes reveals insights about hazards and food quality
Kristen Beck, PhD (DEB Alum)
Research Staff Member,
Industrial and Applied Genomics
IBM Almaden Research Center, San Jose, CA


May 25, 2018

LSA 1022

Careers in patent law (without going to law school) for scientists
Michael Ward, J.D., PhD (UCD Alum)
Partner
Morrison & Foerster LLP,
San Francisco, CA


June 1, 2018
LSA 1022

Taking risks: from grad school to venture capital
Jeni Lee, PhD ((DEB Alum) 
Associate
NovoVentures, Boston, MA

 

 


 

 

 


Reports are due by 5 pm on Friday, June 8, 2018

 

 

 

2018 Winter Schedule

All seminars are scheduled from 11:00am to 12:00pm unless otherwise stated

January 12, 2018
LSA 1022

Organizational Meeting
Dr. Judy Kjelstrom - Co-Instructor, Biotechnology Program & DEB Program Coordinator
Prof. Karen McDonald - Co-Instructor, ECH
Co-Prof. Ray Rodriguez - Co-Instructor, MCB

January 19, 2018
LSA 1022

Bio-Based Fuels & Chemicals: Technology Development and Commercialization at JBEI (Joint BioEnergy Institute)
Peter Matlock, PhD
Director, Technology Commercialization

JBEI: Joint BioEnergy Institute, Emeryville, CA

January 26, 2018
LSA 1022

Converging trends in healthcare: Cross-sector skills for a changing marketplace
Todd Meyerrose, PhD (UCD Alum)
Vice President

P4G Capital,
San Francisco, CA

February 2, 2018
LSA 1022

Next Generation Therapeutics: Designing in CQAs
Vally Kommineni, PhD
Senior Scientist
iBio CMO, Bryan TX

February 9, 2018
LSA 1022

Antimicrobial Proteins Made in Plants as Novel Food Safety Interventions
Daniel Tusé, Ph.D
Owner and Managing Director
DT/Consulting Group, Sacramento, CA


February 16, 2018
LSA 1022

Advanced Microbial Selection (AMS): a unique discovery strategy for microbes that improve plant health and productivity
Susan Turner, PhD
Senior Vice President, Research & Discovery

BioConsortia, Inc., Davis, CA

February 23, 2018

LSA 1022

 

 

 

How a million year old unique seed dispersal mechanism can solve the biggest food problem in the world
Alan Perlstein
CEO

MiraculeX, Inc., San Francisco, CA


March 2, 2018

LSA 1022

If you liked it, you should have put a seq on it
Olga Botvinnik, PhD
Bioinformatics Data Scientist
Chan Zuckerberg Biohub,
San Francisco, CA

March 9, 2018
LSA 1022

Protein-based Drug Discovery and Development at NGM Biopharmaceuticals
Shelley Starck, PhD
Senior Scientist
NGM Biopharmaceuticals, San Francisco, CA

March 16, 2018
LSA 1022

 


 

 

Applying your PhD to Life Science Consulting
Garrick Yuen, PhD
(DEB Alum)
Senior Associate
BluePrint Research Group, San Francisco, CA


 

 


   

Reports are due by 5 pm on Friday, March 23, 2018




 

2017 Fall Schedule

All seminars are scheduled from 11:00am to 12:00pm unless otherwise stated

September 29, 2017
LSA 1022

Organizational Meeting
Dr. Judy Kjelstrom - Co-Instructor, Biotechnology Program & DEB Program Coordinator
Prof. Karen McDonald - Co-Instructor, ECH
Co-Prof. Ray Rodriguez - Co-Instructor, MCB

October 6, 2017
LSA 1022

Big Bang! Kickoff
Niki Peterson, Program Manager, Child Family Institute for Innovation & Entrepreneurship,
Marc Facciotti, PhD, Associate Professor & Assistant Director, TEAM Prototyping Facility Department of Biomedical Engineering, UC Davis Genome Center

October 13, 2017
LSA 1022

What is Intellectual Property?
Maris Apse, PhD, Intellectual Property Officer
UC Davis Innovation Access, UC
Davis

October 20, 2017
LSA 1022

How to Translate Your Research and Ideas Into a Startup
Zane Starkewolfe, PhD (Former DEB Student)
Associate Director,
New Venture Resources, UC Davis

October 27, 2017
LSA 1022

A Tale of Two Drugs
Beiyao Zheng, PhD
, Senior Director of Biometrics
CytomX Therapeutics, Inc.
, San Francisco, CA

November 3, 2017
LSA 1022

Building a Biotech: A Journey From Sweeteners to Schedule 1 Narcotics
Brandon Zipp, PhD, Director of Research and Development, Scientific Co-Founder

Vitality Biopharma Inc, Los Angeles, CA Sponsored by BMCDB Graduate Group

November 10, 2017

Veterans Day - Holiday

November 17, 2017

LSA 1022

Producing Profitable Probiotic Products Professionally: Progressing From PhD Projects to Packaged Pills
Zachary Lewis, PhD
(Former DEB Student) Scientist II - Renew Life
The Chlorox Company,
Pleasanton, CA

November 24, 2017
LSA 1022

Thanksgiving - Holiday

December 1, 2017
LSA 1022

 



December 8, 2017
LSA 1022


 

 

From Genetics to Therapeutics - Leveraging 23andMe Data to Identify Drug Targets
Erik Karrer, PhD (UC Davis Alum) Director, Drug Discovery
Presentation HERE
23andMe Inc,
San Francisco Bay area, CA


Innovating Technologies for Broader and Safer Redirected T-cell Therapies of Cancer
Cheng Liu, PhD
Founder and CEO
Eureka Therapeutics Inc, San Francisco Bay area, CA


 

 


   

Reports are due by 5 pm on Friday, December 15, 2017




 

2017 Spring Schedule

All seminars are scheduled from 11:00am to 12:00pm unless otherwise stated

April 7, 2017
LSA 1022

Organizational Meeting
Dr. Judy Kjelstrom - Co-Instructor, Biotechnology Program & DEB Program Coordinator
Prof. Karen McDonald - Co-Instructor, ECH
Co-Prof. Ray Rodriguez - Co-Instructor, MCB

April 14, 2017
LSA 1022

The Antibody Discovery Paradigm
Aaron K Sato, PhD, Chief Scientific Officer LakePharma, Belmont, CA

April 21, 2017
LSA 1022

Advanced Microbial Selection (AMS): a unique discovery strategy for microbes that improve plant health and productivity
Susan Turner, PhD, Senior Vice President, Research & Discovery
BioConsortia Inc.,
Davis

April 28, 2017
LSA 1022

Turning Ideas Into Medicines: Early Drug Discovery in a Global Pharmaceutical Company
Richard Myers, PhD
Sr. Scientist, Target ID & Validation,
Takeda Pharmaceuticals, San Diego
Presentation Here

May 5, 2017
LSA 1022

From Galaxy Evolution to the Genomics Revolution: Perspectives of a Self-taught Bioinformatician
Jason Harris, PhD

Director, Bioinformatics Engineering, Personalis Inc.
,San Francisco, CA

May 12, 2017
LSA 1022

Why entrepreneurship makes sense
Benjamin R. Wang, MD, Founder and Chief Medical Officer
, NeVap Inc., Emeryville

May 19, 2017
Putah Creek Lodge

ESTEME Colloquium

Navigating a STEM Career in the Pharmaceutical Industry
Donna M. Dambach, VMD, PhD, Diplomate, ACVP, Senior Director, Head of Toxicology, Safety Assessment, Genentech, Inc., San Francisco, CA

May 26, 2017LSA 1022

Putting the D in Biopharmaceutical Research & Development
Matthew Schenauer, PhD

Senior Research Scientist, Gilead Sciences,
Oceanside

June 2, 2017
LSA 1022


 

 

Bio-Based Fuels & Chemicals: Technology Development Development and Commercialization at JBEI (Joint BioEnergy Institute)
Peter Matlock, PhD, Director, Technology Commercialization JBEI: Joint BioEnergy Institute, JBEI: Joint BioEnergy Institute, Emeryville

 


 

 


   

Reports are due by 5 pm on Friday, June 15, 2017